CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride Capsules

Read the official FDA notice

Published
12 Aug 2026
Units affected
6,408 bottles distributed to market
Agency
FDA
Country
United States

The hazard

Shortfill; reports of empty capsules.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

Brand / company
Aurobindo Pharma USA Inc
Codes / lots
Batch # DMC125018A, Exp Date: 07/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.